Lisch epithelial corneal dystrophy: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
Line 1: Line 1:
{{Infobox medical condition (new)
{{Short description|A rare form of corneal dystrophy}}
| synonyms        = Band-shaped and whorled microcystic dystrophy of the corneal epithelium
| name            = Lisch epithelial corneal dystrophy
| image          = X-linked recessive.svg
| image_size      = 150px
| caption        = X-linked recessive is the inheritance pattern of this condition
| pronounce      =
| field          = ophthalmology
| symptoms        =
| complications  =
| onset          =
| duration        =
| types          =
| causes          =
| risks          =
| diagnosis      =
| differential    =
| prevention      =
| treatment      =
| medication      =
| prognosis      =
| frequency      =
| deaths          =
}}
'''Lisch epithelial corneal dystrophy''' (LECD), also known as band-shaped and whorled microcystic dystrophy of the corneal epithelium, is a rare form of [[corneal dystrophy]] first described in 1992 by Lisch et al.<ref name="pmid1621784">{{cite journal |vauthors=Lisch W, Steuhl KP, Lisch C, Weidle EG, Emmig CT, Cohen KL, Perry HD |title=A new, band-shaped and whorled microcystic dystrophy of the corneal epithelium |journal=[[Am. J. Ophthalmol.]] |volume=114 |issue=1 |pages=35–44 |date=July 1992 |pmid=1621784 |doi= 10.1016/S0002-9394(14)77410-0|url=}}</ref> In one study it was linked to chromosomal region Xp22.3, with as yet unknown [[candidate gene]]s.<ref name="pmid11024418">{{cite journal |vauthors=Lisch W, Büttner A, Oeffner F, Böddeker I, Engel H, Lisch C, Ziegler A, Grzeschik K |title=Lisch corneal dystrophy is genetically distinct from Meesmann corneal dystrophy and maps to xp22.3 |journal=[[Am. J. Ophthalmol.]] |volume=130 |issue=4 |pages=461–8 |date=October 2000 |pmid=11024418 |doi= 10.1016/S0002-9394(00)00494-3}}</ref>


The main features of this disease are bilateral or unilateral gray band-shaped and feathery opacities. They sometimes take on a form of a whirlpool, repeating the known pattern of corneal epithelium renewal. Abrasion of the epithelium in 3 patients brought only temporary relief, with abnormal epithelium regrowth in several months.
'''Lisch epithelial corneal dystrophy''' (LECD) is a rare, genetic [[corneal dystrophy]] characterized by distinctive band-shaped and feathery opacities in the [[corneal epithelium]]. It is a non-progressive condition that primarily affects the [[epithelium]] of the [[cornea]], leading to visual disturbances.


Epithelial cells in the zones of opacity were shown to have diffuse cytoplasmic vacuoles with as yet unestablished content.
==Presentation==
LECD typically presents in early childhood or adolescence, although it can be diagnosed at any age. The hallmark of the condition is the presence of grayish, feathery opacities in the corneal epithelium. These opacities are usually bilateral and asymmetric, meaning they affect both eyes but not necessarily to the same degree. The opacities are often described as "whorled" or "feather-like" in appearance.


==References==
Patients with LECD may experience symptoms such as:
{{Reflist}}
* Blurred vision
== External links ==
* Glare sensitivity
{{Medical resources
* Mild discomfort or irritation
|  DiseasesDB    = 
|  ICD10          = H18.5
|  ICD9          = 
|  ICDO          = 
|  OMIM          = 300778
|  MedlinePlus    = 
|  eMedicineSubj  = 
|  eMedicineTopic = 
|  MeshID        = 
|  Orphanet      = 98955
}}
{{Human corneal dystrophy}}


[[Category:Disorders of sclera and cornea]]
The visual impairment is generally mild, and the condition does not typically lead to severe vision loss.


==Pathophysiology==
The exact genetic cause of Lisch epithelial corneal dystrophy is not fully understood, but it is believed to be inherited in an [[X-linked dominant]] pattern. This means that the gene responsible for the condition is located on the [[X chromosome]], and a single copy of the mutated gene is sufficient to cause the disorder in females, while males are more severely affected.


{{eye-disease-stub}}
The opacities in LECD are due to abnormal deposits of [[glycogen]] in the corneal epithelial cells. These deposits disrupt the normal transparency of the cornea, leading to the characteristic visual symptoms.
{{dictionary-stub1}}


== Lisch epithelial corneal dystrophy ==
==Diagnosis==
<gallery>
Diagnosis of LECD is primarily clinical, based on the characteristic appearance of the corneal opacities observed during a [[slit-lamp examination]]. Additional diagnostic tools may include:
File:X-linked_recessive.svg
* [[Corneal topography]] to assess the shape and curvature of the cornea
</gallery>
* [[Confocal microscopy]] to visualize the corneal layers at a cellular level
 
Genetic testing may be used to confirm the diagnosis, especially in cases with a family history of the condition.
 
==Management==
There is currently no cure for Lisch epithelial corneal dystrophy, and management focuses on alleviating symptoms and monitoring the condition. Treatment options may include:
* [[Lubricating eye drops]] to relieve discomfort
* [[Spectacle correction]] for refractive errors
* [[Contact lenses]] to improve visual acuity
 
In rare cases where the opacities significantly impair vision, surgical intervention such as [[phototherapeutic keratectomy]] (PTK) may be considered.
 
==Prognosis==
The prognosis for individuals with LECD is generally good, as the condition is non-progressive and does not typically lead to severe vision loss. Regular follow-up with an [[ophthalmologist]] is recommended to monitor the condition and manage any symptoms.
 
==Related pages==
* [[Corneal dystrophy]]
* [[X-linked dominant inheritance]]
* [[Corneal epithelium]]
 
[[Category:Corneal dystrophies]]
[[Category:Genetic disorders]]

Revision as of 19:08, 22 March 2025

A rare form of corneal dystrophy


Lisch epithelial corneal dystrophy (LECD) is a rare, genetic corneal dystrophy characterized by distinctive band-shaped and feathery opacities in the corneal epithelium. It is a non-progressive condition that primarily affects the epithelium of the cornea, leading to visual disturbances.

Presentation

LECD typically presents in early childhood or adolescence, although it can be diagnosed at any age. The hallmark of the condition is the presence of grayish, feathery opacities in the corneal epithelium. These opacities are usually bilateral and asymmetric, meaning they affect both eyes but not necessarily to the same degree. The opacities are often described as "whorled" or "feather-like" in appearance.

Patients with LECD may experience symptoms such as:

  • Blurred vision
  • Glare sensitivity
  • Mild discomfort or irritation

The visual impairment is generally mild, and the condition does not typically lead to severe vision loss.

Pathophysiology

The exact genetic cause of Lisch epithelial corneal dystrophy is not fully understood, but it is believed to be inherited in an X-linked dominant pattern. This means that the gene responsible for the condition is located on the X chromosome, and a single copy of the mutated gene is sufficient to cause the disorder in females, while males are more severely affected.

The opacities in LECD are due to abnormal deposits of glycogen in the corneal epithelial cells. These deposits disrupt the normal transparency of the cornea, leading to the characteristic visual symptoms.

Diagnosis

Diagnosis of LECD is primarily clinical, based on the characteristic appearance of the corneal opacities observed during a slit-lamp examination. Additional diagnostic tools may include:

Genetic testing may be used to confirm the diagnosis, especially in cases with a family history of the condition.

Management

There is currently no cure for Lisch epithelial corneal dystrophy, and management focuses on alleviating symptoms and monitoring the condition. Treatment options may include:

In rare cases where the opacities significantly impair vision, surgical intervention such as phototherapeutic keratectomy (PTK) may be considered.

Prognosis

The prognosis for individuals with LECD is generally good, as the condition is non-progressive and does not typically lead to severe vision loss. Regular follow-up with an ophthalmologist is recommended to monitor the condition and manage any symptoms.

Related pages